Gossamer Bio Inc GOSS Q1 2026 Earnings WiderthanExpected Loss Weighs on Shares Niagen Bioscience Inc NAGE Q1 2026 Earnings Modest EPS Beat Highlights Operational Discipline Amid Quiet Revenue Reporting EasyJet Losses Deepen Amid Iran WarDriven Fuel Cost Surge and Weakened Demand Harvard Endowment Faces Private Equity Hangover as Succession Looms for Narvekar Roundhill Memory ETF Nearly Doubles Since April Launch Amid AI Memory Shortage Pediatrix Medical Group MD Q1 2026 Earnings EPS Beats Estimates by Nearly 13 as Stock Declines Compass Therapeutics Q1 2026 Earnings Narrower Loss Beats Estimates as Pipeline Progress Takes Center Stage